Page 226 - Medicine and Surgery
P. 226

P1: KPE
         BLUK007-05  BLUK007-Kendall  May 25, 2005  8:52  Char Count= 0








                   222 Chapter 5: Hepatic, biliary and pancreatic systems


                   survival of patients who undergo curative resection is     Many pancreatic endocrine tumours express somato-
                   30%.                                           statin receptors. Radiolabelled octreotide (a somato-
                                                                  statin analogue) can be used for localisation of the
                                                                  primary tumour and detection of any metastases.
                   Islet cell tumours
                                                                    Surgery is the treatment of choice.
                   Insulinoma: Ausually benign islet-cell tumour that may     Several options are available for the treatment of
                   occur in the pancreas or at ectopic sites causing the  metastatic neuroendocrine tumors including oc-
                   hypersecretion of insulin. There may be gradual in-  treotide, interferon α,chemotherapy and hepatic
                   tellectual and motor impairment with insidious per-  artery embolisation.
                   sonality changes. Severe attacks of hypoglycaemia can  Glucagonoma: This is a very rare tumour of the islet cells
                   produce sweating, palpitations, tremulousness and a  of the pancreas which is often asymptomatic. Patients
                   rangeofbizarrepsychoneurologicalbehaviours.Patients  maypresentwithnecrolyticmigratoryerythema,painful
                   may present with a hypoglycaemic coma. Histology  glossitis, stomatitis, gastrointestinal upset, weight loss,
                   shows encapsulated yellow/brown nodules containing  diabetes mellitus and anaemia. Plasma glucagon levels
                   cords and nests of well-differentiated β-cells.  are raised. Imaging and systemic treatment are as for
                                                                insulinoma. Resection of the tumour is usually curative.
                   Investigations/management                    Other islet cell tumours: Very rarely islet-cell tumours
                     Fasting hypoglycaemia with inappropriately high in-  secrete VIP or gastrin. VIPomas cause a profuse wa-

                     sulin secretion (exogenous insulin can be excluded by  tery diarrhoea, hypokalaemia and achlorhydria. The pa-
                     measuring C-peptide levels).               tient may present as an acute abdomen, with ileus and
                     The tumour is found by conventional imaging in less  abdominal distension suggestive of intestinal obstruc-

                     than 50% of cases. Selective venous sampling of con-  tion. Treatment is by resection where possible, or sys-
                     centrations of insulin may be helpful, endoscopic ul-  temic treatment as for insulinoma. Gastrinomas cause
                     trasound is increasingly being used.       the Zollinger–Ellison syndrome (see page 161).
   221   222   223   224   225   226   227   228   229   230   231